For questions or suggestions e-mail us at: ioerger@cs.tamu.edu
VADNPTALVIDLSAVEFLGSVGLKILAATSEKIGQSVKFGVVARGSVTRRPIHLMGLDKTFRLFSTLHDA LTGVRGGRIDR
Operon Prediction Model: Genebank
Paralogs
| species | id | gene | e-value | identity (len) | annotation |
| M. bovis AF2122 / 97 | Mb3712c | - | - | 100% (81) | hypothetical protein Mb3712c |
Closest Orthologs (e-value cutoff: 1e-4)
| species | id | gene | e-value | identity (len) | annotation |
| M. gilvum PYR-GCK | Mflv_3284 | - | 2e-11 | 46.27% (67) | anti-sigma-factor antagonist |
| M. tuberculosis H37Rv | Rv3687c | rsfB | 1e-40 | 100.00% (81) | anti-anti-sigma factor RSFB (anti-sigma factor antagonist) |
| M. leprae Br4923 | - | - | - | - | - |
| M. abscessus ATCC 19977 | - | - | - | - | - |
| M. marinum M | MMAR_5181 | - | 6e-29 | 74.07% (81) | anti-anti-sigma regulatory factor |
| M. avium 104 | MAV_0435 | - | 2e-28 | 75.00% (80) | anti-anti-sigma factor |
| M. smegmatis MC2 155 | MSMEG_6127 | - | 9e-12 | 42.25% (71) | anti-anti-sigma factor |
| M. thermoresistible (build 8) | TH_1832 | - | 1e-18 | 55.84% (77) | ANTI-ANTI-SIGMA FACTOR RSFB (ANTI-SIGMA FACTOR ANTAGONIST) |
| M. ulcerans Agy99 | - | - | - | - | - |
| M. vanbaalenii PYR-1 | Mvan_4702 | - | 6e-13 | 45.83% (72) | anti-sigma-factor antagonist |
CLUSTAL 2.0.9 multiple sequence alignment
Mflv_3284|M.gilvum_PYR-GCK MDEQAAEGTAAGGAPSSTCVVTQRWVDTTAVVAVTGVVDMLTSPQLETAI
MSMEG_6127|M.smegmatis_MC2_155 MTSQD----------PANCTVEERRVGDITVVAVTGTVDMLTAPKLEDAI
Mvan_4702|M.vanbaalenii_PYR-1 -----------------MQQFTEHQIDGVLVVAAVGAVDMLTAPQLQEAI
Mb3712c|M.bovis_AF2122/97 --------------------------------------------------
Rv3687c|M.tuberculosis_H37Rv ----------MSAPDSITVTVADH--NGVAVLSIGGEIDLITAAALEEAI
MMAR_5181|M.marinum_M ----------MSAPDSITAVVTDH--DGVTVLSIGGEIDLVTAPALEEAI
MAV_0435|M.avium_104 -------------------MVEDH--DGVSVVSVSGEIDLVTAPALEQAI
TH_1832|M.thermoresistible__bu --------------------VEHR--DDSAVLRVQGVVDLATGDALQQAI
Mflv_3284|M.gilvum_PYR-GCK DDALNQKPGAVVIDFTEVEFLASAGMGVLVAAHDKAGSEVKISVVADGPA
MSMEG_6127|M.smegmatis_MC2_155 GSAAKSEPSAVVVDLSAVDFLASAGMGVLVAAHGELAPAVRLVVVADGPA
Mvan_4702|M.vanbaalenii_PYR-1 NAALDRQPTGVVVDLTAVDFLGSAGMQVLMTTRRQLEGTVKFAVVADGPA
Mb3712c|M.bovis_AF2122/97 ---MADNPTALVIDLSAVEFLGSVGLKILAATSEKIGQSVKFGVVARGSV
Rv3687c|M.tuberculosis_H37Rv GEVVADNPTALVIDLSAVEFLGSVGLKILAATSEKIGQSVKFGVVARGSV
MMAR_5181|M.marinum_M GAVVADSPTALVIDLSGVEFLGSVGLKILAATYEKLGTAAEFGVVAQGPA
MAV_0435|M.avium_104 GAVVADSPPALVIDLSAVEFLGSVGLKILAATYEKLGKETGFGVVARGPA
TH_1832|M.thermoresistible__bu DDLIATRPSALVVDLSAVDFLASVGLQILVATHERLSPSARFAVVADGPA
* .:*:*:: *:**.*.*: :* :: . . : *** *..
Mflv_3284|M.gilvum_PYR-GCK TSRPLKLVGIADIVALYSNLDEALAARDT-----
MSMEG_6127|M.smegmatis_MC2_155 TSRPLKLVGIADVVDLFATLDEALSSLKT-----
Mvan_4702|M.vanbaalenii_PYR-1 TSRPLKITGIADYVDLFSTLDVALRNLAG-----
Mb3712c|M.bovis_AF2122/97 TRRPIHLMGLDKTFRLFSTLHDALTGVRGGRIDR
Rv3687c|M.tuberculosis_H37Rv TRRPIHLMGLDKTFRLFSTLHDALTGVRGGRIDR
MMAR_5181|M.marinum_M TRRPIHLTGLDKTFPLYPALDDALTGVRDGKLNR
MAV_0435|M.avium_104 TRRPIHLTGLDKTFPLYPTLDDALTAVRDGKLNG
TH_1832|M.thermoresistible__bu TSRPIQLTRLDEVIALYPTLDEALSGVRTGERAE
* **::: : . . *:. *. **